Fibrocell Science Inc (NYSE MKT LLC:FCSC)
| 4.70 Data as of May 15 |  0.00 / 0.00%Today’s Change | 3.02 Today|||52-Week Range 7.50 | +25.33% Year-to-Date |
Latest FCSC News | Press Releases
No recent news for Fibrocell Science Inc.
Today’s Trading
| Previous close | 4.70 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 21,151 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 05/15/2013
Growth & Valuation
| Earnings growth (last year) | +81.47% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | -81.16% |
| P/E ratio | NM |
| Price/Sales | 219.73 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NEONeogenomics Inc | 0.00 | 0.00% |
| MGMistras Group Inc | 0.00 | 0.00% |
| CLDXCelldex Therapeutics... | -0.31 | -2.47% |
| CVDCovance Inc | 0.00 | 0.00% |
Data as of 9:38am ET, 05/23/2013
Financials
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $153.0K |
| Annual profit (last year) | -$23.7M |
| Net profit margin | -15,457.52% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer David Pernock |
Chief Operating & Financial Officer Declan Daly |
Corporate headquarters Exton, Pennsylvania |
Forecasts
